A highly selective agonist for the metabotropic glutamate receptor mGluR2
Simon D. Nielsen(University of Copenhagen), Rasmus P. Clausen(University of Copenhagen), Christian Thomsen(Lundbeck (United States)), Birgitte Nielsen(Kyoto University), Marica Fulco(University of Perugia), Kasper Lykke Hansen(University of Copenhagen), Robb Brodbeck(Lundbeck (United States)), Maria B. Hansen(University of Copenhagen), Jeremy R. Greenwood(Schrodinger (United States)), Hans Bräuner‐Osborne(University of Copenhagen), Michaela Serpi(Cardiff University), Roberto Pellicciari(Bridge Pharma (United States)), Per‐Ola Norrby(University of Gothenburg)
Cited by 10
Related Papers
Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
|Journal of the American Chemical Society|2015|1.4k
Ligands for Glutamate Receptors: Design and Therapeutic Prospects
|Journal of Medicinal Chemistry|2000|525
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors
|Nature Communications|2012|483
Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring
|Journal of Chemical Information and Modeling|2014|465